Notified Bodies and regulatory consultants gave an update on MDR compliance at a recent OSMA meeting. We review their advice on significant change, legacy devices, economic suppliers and more.
Orthopedics, often resilient in times of economic turbulence, faces new complexities with COVID. Our Advisory Board talks contending with the short-term impacts of the pandemic and emerging stronger.
In a perfect world, development is done on time and to budget. However, this isn't a perfect world. Our imperfection is why R&D teams should focus on process improvement to enhance work output.
To unlock the advantages of additive manufacturing, Medtronic sought a partner that could assist with the regulatory path, offer integrated manufacturing and software solutions and expert help.
Cerapedics is one of only two companies with a FDA Class III bone graft technology. The company's leadership team shares how they managed the long road to market.
How is AI shaping orthopedic technology? While the timeline for broader acceptance of AI in orthopedics is uncertain, its vast scope and power is already making an indelible impact.
New providers are being established to assist OEMs in areas like additive manufacturing, materials, manufacturing efficiency and quality. We highlight some new value propositions. (Paid placement).
Intech, MedTorque, N2 Biomedical and Pacific Instruments share what is top of mind for their customers as they’re helping orthopedic companies develop innovative solutions for better patient outcomes.
Analysts predicted that 3D printing would result in a loss of $100 billion per year in IP globally. Here is a look at why enforcing one’s IP against 3D printer infringers will be challenging.
